← Leaderboards
David M Shepherd
Oregon State University
$4,513,927
Attributed
$4,513,927
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $800.3K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,513,927 · 5
By mechanism
R01$4,040,308 · 1
P20$298,664 · 2
R03$145,000 · 1
F32$29,955 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon State University
Same institution · by research overlap
- Robert L Tanguay$34,751,239
- David E. Williams$14,401,927
- Kim A. Anderson$9,268,774
- Staci L Simonich$4,085,497
- William M Baird$2,677,287
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsNatural ImmunosuppressionAryl Hydrocarbon ReceptorAryl Hydrocarbon Receptor LigandImmuneGenerationsEnvironmental PollutionMediatingLigandsImmune ResponsePlayInflammatoryAntigen-Presenting CellsGene TargetingAntigensDioxinsTetrachlorodibenzodioxinT-LymphocyteExposure ToImmune SystemImmunotoxicityAffectSignal TransductionInnovation
Grant awards (20)
Consequences of AhR activation in Dendritic Cells$709,811
R01 · FY2017 · ES · contact PI
Development of a novel platform for the delivery of AhR antagonists to DCs and T cells$382,250
R01 · FY2016 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$338,811
R01 · FY2016 · ES · contact PI
Development of a novel platform for the selective delivery of AhR agonists to DCs.$72,500
R03 · FY2016 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$6,741
R01 · FY2016 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$321,022
R01 · FY2015 · ES · contact PI
Development of a novel platform for the selective delivery of AhR agonists to DCs.$72,500
R03 · FY2015 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$16,022
R01 · FY2015 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$317,723
R01 · FY2014 · ES · contact PI
Consequences of AhR activation in Dendritic Cells$330,177
R01 · FY2013 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$314,747
R01 · FY2010 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$317,981
R01 · FY2009 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$9,730
R01 · FY2009 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$318,034
R01 · FY2008 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$324,104
R01 · FY2007 · ES · contact PI
Consequences of AhR Activation in Dendritic Cells$333,155
R01 · FY2006 · ES · contact PI
MT COBRE: CONSEQUENCES OF AHR-MEDIATED SIGNALING IN DENDRITIC CELLS$153,671
P20 · FY2005 · RR
MT COBRE: AHR-MEDIATED SIGNALING IN DENDRITIC CELLS$144,993
P20 · FY2004 · RR
Characterization of CTIP1 in Immune Cells$29,955
F32 · FY2002 · HL
CONSEQUENCES OF AhR-MEDIATED SIGNALING IN DENDRITIC CELLS$0
P20 · FY2002 · RR